Q2 2014 Holdings
Filed 2014-08-14 | 15 holdings | $224.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Medivation, Inc. | Com | 58501N101 | $175.7K | 2,279,519 | 78.3% |
| Ampio Pharmaceuticals Inc. | Com | 03209T109 | $24.8K | 2,964,401 | 11.0% |
| Alcobra Ltd | SHS | M2239P109 | $11.9K | 687,000 | 5.3% |
| Keryx Biopharmaceuticals Inc. | Com | 492515101 | $3.1K | 200,000 | 1.4% |
| Synthetic Biologics Inc. | COM | 87164U102 | $2.4K | 1,360,000 | 1.1% |
| Newlink Genetics Corp | Com | 651511107 | $2.1K | 77,437 | 0.9% |
| Northwest Biotherapeutics Inc(NWBO) | COM PAR $0.001 | 66737P600 | $1.3K | 200,300 | 0.6% |
| Inovio Pharmaceuticals Inc. | COM NEW | 45773H201 | $1.1K | 102,088 | 0.5% |
| Advaxis Inc. | COM NEW | 7624208 | $709 | 225,000 | 0.3% |
| Galmed Pharmaceuticals Ltd(GLMD) | SHS | M47238106 | $633 | 65,000 | 0.3% |
| Nephrogenex Inc | COMM | 640667101 | $301 | 50,000 | 0.1% |
| Provectus Biopharmaceuticals(PVCT) | COM | 74373P108 | $172 | 200,000 | 0.1% |
| Advaxis Inc. | W EXP 07/15/201 | 7624117 | $115 | 112,500 | 0.1% |
| Celsus Therapeutics Plc | SPONSORED ADR NE | 15119A202 | $78 | 14,155 | 0.0% |
| Echo Therapeutics Inc. | Com New | 27876L206 | $62 | 27,430 | 0.0% |